Ohio State Navbar

Sign In

2nd Cell Therapy Symposium

Second Cell Therapy Symposium: Improving patient outcomes after hematopoietic cell transplantation

Date:        Monday, September 25, 2017
Location: The Grand Event Center
                 820 Goodale Blvd. | Columbus, OH 43212


Nationwide Children’s Hospital and The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute’s Blood and Marrow Transplant Programs, Cell Therapy and Cancer Immunotherapy Programs, and the Host Defense Program are proud to invite you to attend this prestigious conference concerning innovation in cellular transplantation.
Topics will include:
  • Targeting hematologic malignancies using cellular therapies
  • Natural killer cell therapy
  • CAR T-cell therapy: beyond CD19 targeting
  • Bridging the gap in cell therapies: power of partnership between academia and pharma/biotech
  • Modulating immune response by manipulating graft content
  • Cytokine mobilization & cell enrichment and depletion strategies
  • Clinical complications and outcomes after graft content manipulation
Learn more about immune-cell based therapies at Nationwide Children’s and Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute – “Harnessing the immune system: has the cure for cancer been within us all along?”

Speakers:
Marie E. Bleakley, MD, PhD, M.MSC
Seattle Children’s Hospital

Catherine M. Bollard, MBcHB, MD
Children’s National Health System

Laurence J.N. Cooper, MD, PhD
CEO, ZIOPHARM Oncology, Inc.

Andrew M. Corris, PharmD, JD
The Research Institute at Nationwide Children’s Hospital

Dean A. Lee, MD, PhD
Director, Cell Therapy and Cancer Immunotherapy Program at Nationwide Children’s Hospital

Steven M. Devine, MD
Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute

Stephen J. Forman, MD
City of Hope Comprehensive Cancer Center

Aharon G. Freud, MD, PhD
Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute

Philip R. McKee
Board Chairman, Cyto-Sen Therapeutics, Inc.

Wing Leung, MD, PhD
Vice President, Clinical Development, Miltenyi Biotec, Inc.

Sumithira Vasu, MBBS
Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute

For more information, visit NationwideChildrens.org/Courses-Conferences or call 614.355.0650​​